Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 45
- Reported
- 45
- Verified
- 41
- Gap
- +4
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Track; not yet
- Why
- Strong, durable preclinical data (>3-log HBsAg reduction, up to 90% of mice undetectable, >1-year NHP silencing) and a real in-human trial make this a credible programme, but with no human efficacy data yet it is an early clinical bet, not an adoptable result.
- Next
- Watch for the late-2026 Phase 1/2 human safety + HBsAg-loss readout (NCT07200193) and AASLD/Liver Meeting updates before treating epigenetic silencing as clinically de-risked
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 0
- Tier 2
- 4
- Tier 3
- 2
- Supports
- 4
- Contradicts
- 1
- Context
- 1
- Latest observed
- 2026-02-04
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.